MADISON, Wis.--(BUSINESS WIRE)--Aug. 19, 2025--
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.
-
Wells Fargo Healthcare Conference, Boston
Fireside chat on Wednesday, September 3, 2025 at 1:30 p.m. ET
-
Baird Global Healthcare Conference, New York
Fireside chat on Tuesday, September 9, 2025 at 10:50 a.m. ET
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company’s growing portfolio includes well-established brands such as Cologuard® and Oncotype DX®, along with innovative solutions like Oncodetect™ for molecular residual disease and recurrence monitoring. Exact Sciences continues to invest in a robust pipeline of advanced cancer diagnostics aimed at improving outcomes. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20250819553548/en/
Derek Leckow
Exact Sciences Corp.
investorrelations@exactsciences.com
608-893-0009
Source: Exact Sciences Corp.
